Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...
AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Global pharma giant, AbbVie announced today patent license agreements with Mylan over its proposed biosimilar adal...
AbbVie has partnered with Eisai and its gastrointestinal diseases unit EA Pharma to introduce an auto-injection delivery...
Singapore – AbbVie, a research and development-based global biopharmaceutical company, and the International ...
Biogen (BIIB) and AbbVie (ABBV) have announced they are pulling their jointly developed multiple sclerosi...
AbbVie announced a strategic collaboration with South San Francisco-based Alector to develop and commercialize drugs for...
AbbVie, a global research and development-based biopharmaceutical company, opened its Biologics Manufacturing Facility, ...
Global research and development-based bio pharmaceutical company AbbVie is expanding the capabilities of its Singapore o...
Singapore: Global biopharmaceutical company AbbVie has launched small molecule active pharmaceutical ingredient (API) ma...
Singapore: Japanese pharmaceutical companies AbbVie GK, Eisai Co Ltd and its subsidiary EA Pharma Co Ltd have announced ...
Singapore: European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide do...
Singapore:Â US-based AbbVie has announced that the company has submitted a New Drug Application (NDA) to the Japanese ...
Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, h...
Singapore: The drug maker Abbvie, has stated that both the US Food and Drug Administration (USFDA) and European Medicine...
Singapore: Global research-based biopharmaceutical company, Abbvie has expanded its manufacturing base by launching a ne...
Singapore: North Chicago based pharmaceutical company AbbVie has announced in a statement that it will be spending $320 ...
Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel...
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...
Singapore: Abbott has decided to separate its research-based pharmaceuticals business, which will be known as AbbVie. Ab...
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatme...
